Search Results - "SEVELDA, Ursula"

Analysis of trastuzumab and chemotherapy in advanced breast cancer after the failure of at least one earlier combination: an observational study by Bartsch, Rupert, Wenzel, Catharina, Hussian, Dagmar, Pluschnig, Ursula, Sevelda, Ursula, Koestler, Wolfgang, Altorjai, Gabriela, Locker, Gottfried J, Mader, Robert, Zielinski, Christoph C, Steger, Guenther G

“…Combining trastuzumab and chemotherapy is standard in her2/neu overexpressing advanced breast cancer. It is not established however, whether trastuzumab…”
Get full text

Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment by Bartsch, Rupert, Wenzel, Catharina, Pluschnig, Ursula, Hussian, Dagmar, Sevelda, Ursula, Altorjai, Gabriela, Locker, Gottfried J, Mader, Robert, Zielinski, Christoph C, Steger, Guenther G

“…At many centres tumour markers are used to detect disease recurrence and to monitor response to therapy in patients with advanced disease, although the real…”
Get full text

Pain and fertility outcomes of nerve-sparing, full-thickness disk or segmental bowel resection for deep infiltrating endometriosis-A prospective cohort study by Hudelist, Gernot, Aas-Eng, Mee Kristine, Birsan, Tudor, Berger, Franz, Sevelda, Ursula, Kirchner, Lisa, Salama, Mohamad, Dauser, Bernhard

“…Choosing the optimal treatment for bowel endometriosis, ie, conservative vs radical surgery, is under debate. We aimed to evaluate the surgical outcomes of…”
Get more information

Treatment of recurrent platinum-resistant ovarian cancer with pegylated liposomal doxorubicin--an evaluation of the therapeutic index with special emphasis on cardiac toxicity by Steppan, Ilona, Reimer, Daniel, Sevelda, Ursula, Ulmer, Hanno, Marth, Christian, Zeimet, Alain G

“…To study the efficacy of pegylated liposomal doxorubicin (PLD) at a modified dose of 45 mg/m(2) every 4 weeks in platinum-resistant ovarian cancer and to…”
Get more information

Minimal stimulation using recombinant follicle-stimulating hormone and a gonadotropin-releasing hormone antagonist in women of advanced age by Weghofer, Andrea, Margreiter, Markus, Bassim, Sami, Sevelda, Ursula, Beilhack, Elke, Feichtinger, Wilfried

“…To determine whether minimal stimulation with short-term application of low-dose recombinant follicle-stimulating hormone (FSH) together with a…”
Get more information

Oral vinorelbine alone or in combination with trastuzumab in advanced breast cancer : results from a pilot trial by BARTSCH, Rupert, WENZEL, Catharina, PLUSCHNIG, Ursula, HUSSIAN, Dagmar, SEVELDA, Ursula, LOCKER, Gottfried J, MADER, Robert, ZIELINSKI, Christoph C, STEGER, Guenther G

“…We evaluated the efficacy of oral vinorelbine (OV) (Navelbine oral Boeringer-Ingelheim Austria) in patients with advanced breast cancer as first-line therapy…”
Get full text

Preoperative chemotherapy with epidoxorubicin, docetaxel and capecitabine plus pegfilgrastim in patients with primary breast cancer by Wenzel, Catharina, Bartsch, Rupert, Locker, Gottfried J, Hussian, Dagmar, Pluschnig, Ursula, Sevelda, Ursula, Gnant, Michael F, Jakesz, Raimund, Zielinski, Christoph C, Steger, Guenther G

“…The objective of this pilot trial was to evaluate the safety and activity profile of epidoxorubicin, docetaxel and oral capecitabine plus pegfilgrastim (TEX+P)…”
Get full text

Darbepoetin α as treatment for anemia in patients receiving chemotherapy: a single-center experience by Bartsch, Rupert, Wenzel, Catharina, Sevelda, Ursula, Hussian, Dagmar, Pluschnig, Ursula, Locker, Gottfried J, Mader, Robert, Zielinski, Christoph C, Steger, Guenther G

“…We evaluated Darbepoetin α (Aranesp; Amgen), a novel erythropoietic protein, in patients who developed anemia while receiving chemotherapy. Seventy-five…”
Get full text

Carboplatin and nonpegylated liposomal doxorubicin in primary advanced or recurrent endometrial cancer: a phase 2 trial conducted by AGO Austria by Volgger, Birgit, Zeimet, Alain G, Reinthaller, Alexander, Petru, Edgar, Schauer, Christian, Klein, Michaela, Sevelda-Schwarzgruber, Ursula, Bogner, Gerhard, Wolfram, Gerhard, Marth, Christian

“…Recurrent/advanced endometrial carcinoma carries a poor prognosis. Chemotherapy usually consists of cisplatin/doxorubicin and paclitaxel or the doublet of…”
Get more information

Darbepoetin ?? as treatment for anemia in patients receiving chemotherapy: a single-center experience by Bartsch, Rupert, Wenzel, Catharina, Sevelda, Ursula, Hussian, Dagmar, Pluschnig, Ursula, Locker, Gottfried J., Mader, Robert, Zielinski, Christoph C., Steger, Guenther G.

Get full text

Zoledronate in a patient with pamidronate refractory hypercalcemia syndrome by Wenzel, Catharina, Bartsch, Rupert, Hussian, Dagmar, Pluschnig, Ursula, Locker, Gottfried J, Sevelda, Ursula, Zielinski, Christoph C, Steger, Guenther G

“…Hypercalcemia of malignancy remains a common metabolic complication of advanced cancer often resulting in considerable morbidity and diminishing life quality…”
Get full text